Kingdon Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Kingdon Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-941,348	Closed	-$1.63M	–	167
2016 Q4	$1.63M	Sell	941,348 -17,474	-2%	-$30.8K	0.11%	112
2016 Q3	$1.86M	Hold	958,822	–	–	0.12%	102
2016 Q2	$1.67M	Sell	958,822 -98	-0%	-$203	0.14%	93
2016 Q1	$1.29M	Sell	958,920 -35,000	-4%	-$43.4K	0.1%	100
2015 Q4	$1.68M	Buy	993,920 +43,920	+5%	+$71.6K	0.13%	105
2015 Q3	$1.84M	Buy	+950,000	New	+$2.59M	0.15%	108

Other funds holding CBAY

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $186M AUM 35.8% 1-Year Est. Return

Ghost Tree Capital New York $276M AUM 70.11% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return